Faculty of Pharmacy UNAIR Hosts the 2025 ACCP Board Meeting, Contributing to the Creation of an Inclusive Clinical Pharmacy Ecos
26 Juli 2025

Faculty of Pharmacy UNAIR Hosts the 2025 ACCP Board Meeting and Contributes to Creating an Inclusive Clinical Pharmacy Ecosystem
The Faculty of Pharmacy, Airlangga University (FF UNAIR), hosted the Asian Conference on Clinical Pharmacy (ACCP) Board Meeting on July 24, 2025. This prestigious annual meeting was attended by board members from various countries, including Australia, China, Indonesia, Japan, South Korea, Malaysia, the Philippines, Singapore, Thailand, the United States, Vietnam, and Brunei. The meeting discussed several strategic agendas related to the future of the organization.
The meeting, chaired by the current ACCP President, Dr. Helen Zhang, Pharm.D., resulted in important decisions, including the election of Hazel Faye R. Docuyanan, RPh., M.Sc., as the new ACCP President for the 2025-2027 term.
The meeting agreed to accept Brunei as a new member of the ACCP organization. New Zealand and Mongolia were also proposed as candidates for new members. This expansion marks an important step in expanding the ACCP's global collaboration network.
Dr. Helen Zhang also encouraged board members to focus on improving the quality of the ACCP's official journal, "Research in Clinical Pharmacy," which is currently being developed to become a reputable Scopus-indexed journal. Discussions covered editorial management, manuscript quality improvement, and expanding scientific contributions from member countries.
As the host of the ACCP 2025, Faculty of Pharmacy UNAIR also presented a conference report by Dr. Yunita Nita, the Chief Executive. Also introduced were the leadership of Faculty of Pharmacy UNAIR, the main organizer, and leaders from other institutions that collaborated in organizing ACCP 2025.
The active involvement of Dr. apt. Yunita Nita, S.Si., M.Pharm. and apt. Elida Zairina, S.Si., MPH., PhD. as ACCP board members, and Prof. Dr. apt. Suharjono, MS., as an honorary board member, demonstrates the important role and presence of Faculty of Pharmacy UNAIR in the development of clinical pharmacy at the global level.
This board meeting is expected to strengthen international networking, scientific accessibility and communication, and create a more inclusive, sustainable, and evidence-based clinical pharmacy ecosystem.
This activity embodies Faculty of Pharmacy UNAIR's full support for SDGs 3 "Good Health and Well-being" and SDG 17 "Partnerships for the Goals."